Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPPharmacoTherapy, -Epidemiology & -Economics (PTEE)

Theses

Date

Theses
2017-06-02

Jan Peter Yska

Prof dr EN van Roon
Prof dr B Wilffert

Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet

2017-04-24

Nur Aizati Athirah Daud

Prof dr B Wilffert
Dr JEH Bergman

Paving ways for personalizing drug therapy during pregnancy

2017-02-17

Didik Setiawan

Prof dr MJ Postma
Prof dr B Wilffert

HPV vaccination in Indonesia: A health-economic & comparative perspective

2016-12-09

Nyashadzaishe Mafirakureva

Prof dr MJ Postma
Dr M van Hulst
Dr S Khoza

Health economics of blood transfusion in Zimbabwe

2016-12-09

Tonderai Mapako

Prof dr MJ Postma
Dr M van Hulst

Risk modelling of transfusion transmissible infections

2016-11-18

Renata Å mit

Prof dr MJ Postma
Prof dr K Poelstra

Health economics of tick-borne diseases

2016-09-23

Lan Nguyen

Prof dr MJ Postma
Dr CCM Schuiling-Veninga
Dr Nguyen Thi Bach Yen
Dr EP Wright

Health economics of screening for hypertension in Vietnam

2016-09-12

Jovan Mihajlović

Prof dr MJ Postma
Dr P Pechlivanglou

Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands

2016-06-21

Maryam Darvishian

Prof dr E Hak
Prof dr ER van den Heuvel

Real-world influenza vaccine effectiveness: New designs and methods to adjust for confounding and bias

2016-06-17

Hans-Joerg Fugel

Prof dr MJ Postma
Dr M Nuijten
Dr K Redekop

Economics of stratified medicine

2016-06-17

Lisette Berm

Prof dr B Wilffert
Prof dr E Hak

Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean

2016-03-11

Maarten Bijlsma

Prof dr E Hak
Prof dr S Vansteelandt

Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology

2016-03-02

Linda de Jong

Prof dr IM van Langen
Prof dr LTW de Jong- van den Berg

Data quality and methodology in studies on maternal medication use in relation to congenital anomalies
2016-02-26

Dianna de Vries

Prof dr E Hak
Prof dr P Denig
Prof dr MJ Postma

Statin treatment in type 2 diabetes patients

2016-02-19

Bianca Mulder

Prof dr E Hak
Prof dr SS Jick

Medication use during pregnancy and atopic

2016-01-25

Priscilla Zetstra-van der Woude

Prof dr LTW de Jong-van den Berg

Data collection on risk factors in pregnancy

2015-12-22

Jelena Stevanovic

Prof dr MJ Postma

Pharmacoeconomics of cardiovascular disease prevention

2015-12-04

Koen Pouwels

Prof dr E Hak

Self-controlled designs to control confounding

2015-11-17

Jan Wijnia

Prof dr CI Mulder
Prof dr AJM Loonen

Early detection of mental and motor symptoms in the Wernicke-Korakoff Syndrome

2015-09-25

Job van Boven

Prof dr MJ Postma
Prof dr T van der Molen

Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness

2015-09-16

John Pitman

Prof dr MJ Postma
Prof dr TS van der Werf

The influence and impact of the U.S. President's Emergency Plan for AIDS Relief (PERFAR) on blood transfusin services in Africa. Case studies from Namibia

2015-06-26

Marlies Geurts

Prof dr JJ de Gier
Prof dr JRBJ Brouwers
Prof dr PA de Graeff

Integrated Pharmaceutical Care. Cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan

2015-05-29

Nikolas Kotsopoulos

Prof dr MJ Postma
Dr M Connolly

Novel economic perspectives on prevention and treatment: case studies for paediatric, adolescent and adult infectious and chronic diseases

2015-05-29

Bo Standaert

Prof dr MJ Postma
Prof dr O Ethgen

Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease

2015-05-01

Bart Heeg

Prof dr MJ Postma
Prof dr E Buskens
Prof dr BA van Hout

Modelling chronic diseases for reimbursement purposes

2014-11-03

Thao Huong Nguyen

Prof dr K Taxis
Prof dr FM Haaijer-Ruskamp
Prof dr JRBJ Brouwers

Medication Safety in Vietnamese Hospitals. A focus on medication errors and safety culture

2014-06-27

Auliya Suwantika

Prof dr MJ Postma
Dr K Lestari

Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case

2014-05-28

Giedre Gefenaite

Prof dr E Hak
Prof dr RP Stolk

Newly introduced vaccines. Effectiveness and deterninants of acceptance

2014-04-07

Susana Monteiro

Prof dr JJ de Gier
Dr ir L van Dijk

Driving-impairing Medicines and Traffic Safety. Patients' Perspectives

2013-10-28

Josien Riphagen-Dalhuisen

Prof dr E Hak

Influenza vaccination of health care workers

2013-10-25

Fenneke van Hasselt

Prof dr AJM Loonen
Prof dr MJ Postma
Dr MJT Oud
Dr PFM Krabbe

Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions

2013-09-13

Mehraj Parouty

Prof dr MJ Postma

Inequality Aversion to Posterity: Discounting Human Lives

2013-06-28

Hoa Dinh Vu

Prof dr JRBJ Brouwers
Prof dr DRA Uges
Prof dr VH Le†/ Prof dr DH Nguyen

Clinical Pharmacology of Tuberculosis Drugs and Tuberculosis Control in Developing World. The involvement of Private Pharmacy and the individualization of treatment using Dried blood spot

2013-06-07

Timothy Broesamle

Prof dr JJ de Gier
Prof dr JJ van der Werf

Designing Health Care Services Using Systems Thinking: A Theory, A Method and their Application in the Dutch Community Pharmacy

2013-05-31

Josta de Jong

Prof dr LTW de Jong-van den Berg
Dr TW de Vries

Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands

2013-04-17

Tjalke Westra

Prof dr MJ Postma
Prof dr JC Wilschut
Prof dr CAHH Daemen
Prof dr HW Nijman

Healt-economic Modelling of Human Papillomavirus Vaccination

2013-03-22

Irene Lako

Prof dr K Taxis
Prof dr D Wiersma

Depressive Symptoms in Patients with Schizophrenia. Count symptoms that Count

2013-02-25

Mark Rozenbaum

Prof dr MJ Postma
Prof dr E Hak

Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease

2013-02-25

Albert Jan van Hoek

Prof dr MJ Postma
Prof dr WJ Edmunds
Prof dr E Miller

The Epidemiology and Cost-effectiveness of Vaccination Strategies against Infectious Diseases: a Focus on Varicella Zoster, Pandemic influenza A/H1N1 2009, Streptococcus Pneumonia

2013-01-11

Peter ter Horst

Prof dr B Wilffert
Prof dr LTW de Jong-van den Berg

Clinical Pharmacology of Antidepressants During Pregnancy

2012-12-18

Petros Pechlivanoglou

Prof dr MJ Postma
Prof dr JE Wierinnga

Applying and Extending Mixed-effects Models in Health Economics and Outcomes Research

2012-11-16

Ineke Crijns

Prof dr LTW de Jong-van den Berg

Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes

2012-10-10

Janna Munster

Prof dr E Hak

Prof dr JG Aaarnoudse

Q Fever During Pregnancy. Lessons From the Dutch Epidemic

2012-06-04

Linda Harmark

Prof dr AC van Grootheest
Prof dr JJ de Gier

Web-based intensive monitoring : a patient based pharmacovigilance tool

2012-03-16

Stefan Vegter

Prof dr MJ Postma
Prof dr G Navis

The value of personalized approaches to improve pharmacotherapy in renal disease

2012-02-24

Silvia Ravera

Prof dr JJ de Gier
Prof dr LTW de Jong vd berg

Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication

2012-01-27

Hong Anh Thi Tu

Prof dr MJ Postma

Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam

2011-12-09

Janneke Boersma-Jentink

Prof dr LTW de Jong vd berg
Prof dr H Dolk

Risk assessment of antiepileptic drugs in pregnancy

2011-11-18

Florence van Hunsel

Prof dr AC van Grootheest
Prof dr LTW de Jong vd berg

The contribution of direct patient reporting to pharmacovigilance

2011-02-04

Evert Jan Mookhoek

Prof dr AJM Loonen
Prof dr JRBJ Brouwers

Patterns of somatic disease in residential psychiatric patients : surveys of dyspepsia, diabetes and skin disease

2011-02-04

Anna Krabbe Lugner

Prof dr MJ Postma
Dr J Wallinga

Cost-effectiveness of controlling infectious diseases from a public health perspective

2010-10-08

Michiel Duyvendak

Prof dr JRBJ Brouwers

Pharmaceutical care by clinical pharmacists in patients with musculoskeletal disease

2010-04-16

Mark Connolly

Prof dr MJ Postma
Prof dr W Ledger

The Economics of assisted reproduction. Costs and consequences of fertility treatments

2010-01-11

Marian Bakker

Prof dr CHCM Buijs
Prof dr LTW de Jong vd berg

The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy

2010-01-08

Susanne Schorr

Prof dr K Taxis
Prof dr JRBJ Brouwers

Drug safety in patients with psychotic disorders

2010-01-08

Robin de Vries

Prof dr MJ Postma
Prof dr LTW de Jong vd berg

Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making

2009-11-09

Asmar Al Hadithy

Prof dr JRBJ Brouwers
Prof dr AJM Loonen

Pharmacogenetics of Antipsychotic-Induced Parkinsonism and Tardive Dyskenesia: a Focus on African-Caribbeans and Slavonic Caucasians

2009-06-26

Maarten Beinema

Prof dr JRBJ Brouwers
Prof dr J vd Meer

The optimization of coumarin anticoagulant therapy: Pharmacogenetics and computer assisted dose finding

2009-06-12

Cornelis Boersma

Prof dr MJ Postma
Prof dr LTW de Jong vd berg
Prof dr PE de Jong

Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings

2009-05-11

Gijs Hubben

Prof dr MJ Postma

Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making

2009-03-20

Fokaline Vroom

Prof dr LTW de Jong vd berg
Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar

Drug use in pregnancy. Exploring the field of DMARDs in pregnancy

2008-11-28

Mark Reinders

Prof dr JRBJ Brouwers
Prof dr MAFJ vd Laar

Practice research in the field of gout. Clinical pharmacology of antihyperuricemic drugs

2008-11-14

Tjalling de Vries

Prof dr LTW de Jong vd berg
Prof dr EJ Duiverman

Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles

2008-10-17

Beitske Smink

Prof dr DRA Uges
Prof dr ACG Egberts
Prof dr jj de Gier

Benzodiazepines and traffic safety. Forensic, analytical-toxicological and epidemiological aspects of driving under the influence of benzodiazepines

2006-12-08

Willemijn Meijer

Prof dr LTW de Jong vd berg
Prof dr JRBJ Brouwers

Drug safety in pregnancy. Studying and communicating teratogenic risks

2006-10-02

Adrianne Faber

Prof dr LTW de Jong vd berg

Stimulant treatment in children: a Dutch perspective

2006-09-15

Jarir Atthobari

Prof dr LTW de Jong vd berg
Prof dr PE de Jong

Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects

2006-06-30

Rogier Klok

Prof dr JRBJ Brouwers
Prof dr MJ Postma

Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection

2005-05-11

Frank Jansman

Prof dr JRBJ Brouwers
Prof dr DTh Sleijfer

Chemotherapy for patients with colorectal Cancer

2005-03-11

Eric van Roon

Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar

Practice research in the field of rheumatoid arthritis

2004-12-17

Ada Stuurman-Bieze

Prof dr LTW de Jong vd berg
Dr ThFJ Tromp

Interventions on the principle of Pulmonary Medication Profiles

2004-11-19

Andrea Tramarin

Prof dr JRBJ Brouwers
Dr MJ Postma

The changing economic burden of HIV/AIDS in Italy

2004-01-09

Jasper Bos

Prof dr LTW de Jong vd berg
Dr MJ Postma

Pharmacoeconomics in infectious disease. The evaluation of prevention programmes

2003-12-01

Vera Deneer  

Prof dr JRBJ Brouwers
Prof dr JH Kingma

Episodic tretment and prevention of paroxysmal atrial fibrilation: studies on flecainide and sotalol

2003-11-18

Kees van Grootheest

Prof dr LTW de Jong vd berg
Dr EP van Puijenbroek

Improving Pharmacovigilance and the Role of the Pharmacist

2003-10-03

Eric Schirm

Prof dr LTW de Jong vd berg
Dr H Tobi

Drug Exposure from conception till adulthood

2003-10-03

Claudia Rijcken

Prof dr LTW de Jong vd berg

Pharmacy Data as a Tool for assessing Antypsychotic Drug Use

2003-01-31

Taco Monster

Prof dr LTW de Jong vd berg
Prof dr PE de Jong
Dr H Tobi

Assessing drug influences on urinary albumin excretion

2002-06-07

Karen van Dijk

Prof dr LTW de Jong vd berg
Prof JRBJ Brouwers

pharmacotherapy in frail elderly

2002-02-22

Patricia van den Bemt

Prof dr JRBJ Brouwers
Prof dr ACG Egberts

Drug safety in hospitalised patients

2001-11-10

Nicolien Wieringa

Prof dr R Vos
Prof dr PA de Graeff

marketing Clinical Research and Medical Practice: the case of cardiovascular drugs

2001-06-18

Hermien de Walle

Prof dr CHCM Buys
Prof dr LTW de Jong vd berg

Awareness and use of folic acid in the Netherlands: from science to practice

2001-05-04

Roel Fijn

Prof dr LTW de Jong vd berg
Prof dr JRBJ Brouwers

Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines?

2001-01-19

Marc Weeber

Prof dr R Vos
Prof dr LTW de Jong vd berg

Literature-based Discovery in Biomedicine

2000-06-21

Jennita Reefhuis

Prof dr CHCM Buys
Prof dr LTW de Jong vd berg

The Use of Birth Defect Registries for Etiological Research.
2000-01-28

Foppe van Mil

Prof dr ThFJ Tromp
Prof dr LTW de Jong vd berg
Prof dr J McElnay

Pharmaceutical care, the future of pharmacy

1998-10-16

Corinne de Vries

Prof dr LTW de Jong vd berg
Prof dr ThFJ Tromp

Collaboration in healthcare, the tango to drug safety

1998-01-30

Floor Rikken

Prof dr R Vos
Prof dr DKF Meijer
Prof dr W van Rossum

Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs

1995-09-22

Anke van Trigt

Prof dr ThFJ Tromp
Prof dr MNG Dukes
Prof dr FM Haaijer-Ruskamp
Dr LTW de Jong vd Berg

Making News about Medicines

1995-07-07

Miriam Sturkenboom

Prof dr H Wesseling
Prof dr DKF Meijer
Dr LTW de Jong vd Berg

A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin

1992-04-29

Lolkje de Jong-van den Berg

Prof dr MNG Dukes
Prof dr H Wesseling

Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment?

1989-12-11

Rein Vos

Prof dr DKF Meijer
Prof dr AJ Dunning
Prof dr TAF Kuipers
Dr HWHJ Bodewitz

Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists

Laatst gewijzigd:08 augustus 2017 09:36